Those who have already made the transition to using AI are reaping the benefits of vastly accelerated workflows and targeted decision-making in data analysis. But for bioinformaticians who remain on the fence, there are challenges to consider when taking the leap.
Using AI in bioinformatics is on the agenda for a Palmy Bioinfo meeting next year. Lots to discuss, from the practical 'How do you do this' to the ethics of code scraping against software licenses. Quite interesting the Nature is suggesting that people get on the bandwagon or experience FOMO.
Comments
Relatedly, a Federal Trade Commission (USA) held a round table discussion about "Creative Economy and Generative AI". Further information and a recording are at the link below.
This discussion on MetaFilter is focused on writing rather than code. It includes thoughts in regards to copyright which is applicable in both cases.